Sequencing cell-free DNA may be able to provide baseline information on actionable mutations and improve the quality of care in colorectal cancer. READ MORE
A novel scoring system may identify elderly patients with advanced gastric cancer who may not benefit from chemotherapy.
A pilot program for Direct Access Colonoscopy Screening increased overall screening rates for colorectal cancer by nearly 100%.
Costs associated with maintenance bevacizumab and capecitabine.
Sequencing cell-free DNA may be able to provide baseline information on actionable mutations and improve the quality of care in colorectal cancer.
A re-analysis of 2016 data from the USPSTF on colorectal cancer screening indicates that flexible sigmoidoscopy reduces the risk of death.
Systemic inflammation combined with sarcopenia could double the risk of death in patients with colorectal cancer, suggesting that these markers have clinical predictive value.
For patients with complications after colorectal surgery, being readmitted to the same medical center and being cared for by the surgeon who performed the operation may increase the likelihood of survival.
Research in Review
A recent study combined and analyzed data from three trials regarding the use of first-line chemotherapy plus selective internal radiotherapy in patients with colorectal cancer and liver metastases.
A majority of older patients with stage II or III rectal adenocarcinoma do not receive standard-of-care treatment.
A recent study compared the effects of first-line chemotherapy with two different drugs in patients with advanced or metastatic colorectal cancer.